Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies

PURPOSE: To define dose limiting toxicities (DLTs) and the maximum tolerated dose (MTD) of capecitabine with fixed-dose rate (FDR) gemcitabine. PATIENTS AND METHODS: Eligible adults (advanced solid tumor; performance status ≤ 2) received capecitabine 500mg/m(2) PO BID days 1-14 and FDR gemcitabine (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Attia, Steven, Morgan-Meadows, Sherry, Holen, Kyle D., Bailey, Howard H., Eickhoff, Jens C., Schelman, William R., Traynor, Anne M., Mulkerin, Daniel L., Campbell, Toby C., McFarland, Thomas A., Huie, Michael S., Cleary, James F., Tevaarwerk, Amye J., Alberti, Dona B., Wilding, George, Liu, Glenn
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2676212/
https://ncbi.nlm.nih.gov/pubmed/18841362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-008-0844-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados